Research ArticleArticle
Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120
Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
Molecular Pharmacology May 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949
Rudi Prihandoko
Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom (R.P., A.J.B., A.B.T.); Molecular Pharmacology Group, Institute of Molecular, Cell, and Systems Biology (E.A.-C., B.D.H., G.M.), and Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary, and Life Sciences (A.M.M.), University of Glasgow, Glasgow, United Kingdom; and Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark (T.U.)
Elisa Alvarez-Curto
Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom (R.P., A.J.B., A.B.T.); Molecular Pharmacology Group, Institute of Molecular, Cell, and Systems Biology (E.A.-C., B.D.H., G.M.), and Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary, and Life Sciences (A.M.M.), University of Glasgow, Glasgow, United Kingdom; and Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark (T.U.)
Brian D. Hudson
Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom (R.P., A.J.B., A.B.T.); Molecular Pharmacology Group, Institute of Molecular, Cell, and Systems Biology (E.A.-C., B.D.H., G.M.), and Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary, and Life Sciences (A.M.M.), University of Glasgow, Glasgow, United Kingdom; and Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark (T.U.)
Adrian J. Butcher
Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom (R.P., A.J.B., A.B.T.); Molecular Pharmacology Group, Institute of Molecular, Cell, and Systems Biology (E.A.-C., B.D.H., G.M.), and Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary, and Life Sciences (A.M.M.), University of Glasgow, Glasgow, United Kingdom; and Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark (T.U.)
Trond Ulven
Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom (R.P., A.J.B., A.B.T.); Molecular Pharmacology Group, Institute of Molecular, Cell, and Systems Biology (E.A.-C., B.D.H., G.M.), and Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary, and Life Sciences (A.M.M.), University of Glasgow, Glasgow, United Kingdom; and Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark (T.U.)
Ashley M. Miller
Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom (R.P., A.J.B., A.B.T.); Molecular Pharmacology Group, Institute of Molecular, Cell, and Systems Biology (E.A.-C., B.D.H., G.M.), and Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary, and Life Sciences (A.M.M.), University of Glasgow, Glasgow, United Kingdom; and Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark (T.U.)
Andrew B. Tobin
Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom (R.P., A.J.B., A.B.T.); Molecular Pharmacology Group, Institute of Molecular, Cell, and Systems Biology (E.A.-C., B.D.H., G.M.), and Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary, and Life Sciences (A.M.M.), University of Glasgow, Glasgow, United Kingdom; and Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark (T.U.)
Graeme Milligan
Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom (R.P., A.J.B., A.B.T.); Molecular Pharmacology Group, Institute of Molecular, Cell, and Systems Biology (E.A.-C., B.D.H., G.M.), and Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary, and Life Sciences (A.M.M.), University of Glasgow, Glasgow, United Kingdom; and Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark (T.U.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Phosphorylation Profile of mFFA4 Determines Signaling
Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
Molecular Pharmacology May 1, 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949
Research ArticleArticle
Phosphorylation Profile of mFFA4 Determines Signaling
Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
Molecular Pharmacology May 1, 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement